Akiko Miyazaki

Matsumoto, 3908621, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.

Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.

Journal: Bone

Published: April 20, 2022

Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis.

Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis.

Journal: Clinical nutrition ESPEN

Published: October 31, 2021

Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.

Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.

Journal: Modern rheumatology

Published: September 07, 2021

Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting.

Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting.

Journal: Nutrients

Published: April 21, 2021

Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: A case report.

Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: A case report.

Journal: Modern rheumatology case reports

Published: April 09, 2021

Associations of Homocysteine Metabolism With the Risk of Spinal Osteoarthritis Progression in Postmenopausal Women.

Associations of Homocysteine Metabolism With the Risk of Spinal Osteoarthritis Progression in Postmenopausal Women.

Journal: The Journal of clinical endocrinology and metabolism

Published: April 07, 2021

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.

Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.

Journal: Bone reports

Published: January 30, 2021

Denosumab versus romosozumab for postmenopausal osteoporosis treatment.

Denosumab versus romosozumab for postmenopausal osteoporosis treatment.

Journal: Scientific reports

Published: January 06, 2021

Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers.

Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers.

Journal: Scientific reports

Published: July 30, 2020

Showing 1-9 of 9

Last Updated: 09/26/2026